|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Displaying 201 - 220 of 869 stories.
May 24, 2012
DSM says it has appointed Laura L. Parks as president and business unit director of DSM Pharmaceuticals (Greenville, NC), the finished dosage business of DSM Pharmaceutical Products...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSM-Appoints-New-Head-of-Pharmaceutical-Finished-Dosage-Business_43723.html May 22, 2012
Codexis (Redwood City), an enzymes technology firm, says Merck has signed a three-year extension to an ongoing catalyst and process development collaboration for pharmaceutical...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-Extends-Enzymes-Collaboration-with-Codexis_43675.html May 22, 2012
MITSUBISHI TANABE PHARMA EXITS FINE CHEMICALS BUSINESS Mitsubishi Tanabe Pharma (Osaka, Japan) says it will exit the fine chemicals business and transfer its fine chemical operations...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-22_43661.html May 21, 2012
Mitsubishi Tanabe Pharma (Osaka, Japan) says it will exit the fine chemicals business and transfer its fine chemical operations to two companies. Mitsubishi Tanabe Pharma’s...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mitsubishi-Tanabe-Pharma-Exits-Fine-Chemicals-Business_43627.html May 17, 2012
Codexis (Redwood City, CA) says that the United States Patent and Trademark Office (USPTO; Alexandria, VA) has granted Codexis’ patent covering the biocatalysts and biocatalytic...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/USPTO-Grants-Codexis-Patent-for-Enzymes-Used-in-Hepatitis-C-Therapeutics_43535.html May 16, 2012
GlaxoSmithKline (GSK; London) says it has entered into an agreement to acquire those shares it does not currently own in privately held Cellzome (Heidelberg, Germany), a leader in the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-Acquires-Chemical-Proteomics-Company_43494.html May 16, 2012
Lonza and Avalanche Biotechnologies (San Francisco, CA), a privately held biotechnology company, have formed a manufacturing collaboration focused on process development and scale-up...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-and-Avalanche-Biotechnologies-Form-Manufacturing-Collaboration_43493.html May 15, 2012
BASF ACQUIRES EQUATEQ, A MANUFACTURER OF OMEGA-3 FATTY ACIDS FOR PHARMACEUTICALS BASF says it has acquired Equateq (Isle of Lewis, U.K.), a global leader in the manufacturing of highly...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-15_43470.html May 15, 2012
Ampac Fine Chemicals (AFC; Rancho Cordova, CA), a subsidiary of American Pacific Corp. (Las Vegas, NV), has recorded an operating loss of about $1 million in its fiscal second quarter...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Ampac-Fine-Chemicals-Reports-an-Operating-Loss_43469.html May 15, 2012
Asahi Glass (Tokyo) says it has decided to invest about ¥800 million ($10 million) to build a new production line for Tafluprost, an active pharmaceutical ingredient (API) for...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Asahi-Glass-to-Double-Production-Capacity-for-Tafluprost-API_43468.html May 15, 2012
Hikal (Mumbai), an outsourcing partner to companies in the pharma, biotech, agchem, and specialty chemical industries, has recorded a 7% increase in net profits for its fiscal fourth...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hikal-Reports-Rise-in-Profits-and-Sales_43467.html May 9, 2012
Novozymes says its Novozymes Biopharma business has begun commercial supply of hyaluronic acid from a previously announced new plant at Tianjin, China. The newly opened plant involved...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Novozymes-Opens-Hyaluronic-Acid-Plant-in-China_43308.html May 9, 2012
BASF says it has acquired Equateq (Isle of Lewis, U.K.), a global leader in the manufacturing of highly concentrated omega-3 fatty acids. Financial details of the deal were not...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/BASF-Acquires-Equateq-a-Manufacturer-of-Omega-3-Fatty-Acids-for-Pharmaceuticals_43304.html May 8, 2012
LONZA ON TRACK TO MEET 2012 TARGETS Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-8_43278.html May 8, 2012
DSM says that the performance of the company’s pharmaceutical business in the first quarter of 2012 remained weak, although first signs of improvement are visible. The...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/DSMs-Pharma-Business-Reports-Weak-Results-in-First-Quarter_43275.html May 4, 2012
Lonza, in its business update announcement for the first quarter of 2012, says that the company’s business performance was in line with expectations in the quarter. Capacity...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-on-Track-to-Meet-2012-Targets-Arch-Integration-Progressing-Well_43219.html May 4, 2012
Cambrex (East Rutherford, NJ) reported a more than doubling in net profits for the first quarter ended March 31, 2012, compared with the year-ago quarter, to $7 million. Net sales for...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-Reports-Rise-in-Profits-and-Sales_43220.html May 1, 2012
Materia (Pasadena, CA), a catalyst firm with an exclusive license for Grubbs catalyst technology, has received a Phase II Fast Track Small Business Technology Transfer grant from the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Materia-Secures-NIH-Funding-to-Develop-Alternative-Reagents_43143.html May 1, 2012
WATSON PHARMACEUTICALS TO ACQUIRE ACTAVIS FOR $5.6 BILLION Watson Pharmaceuticals (Parsippany, NJ), a leading manufacturer of generic, branded and biologic pharmaceutical products, and...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-May-1_43141.html May 1, 2012
GlaxoSmithKline (GSK; London) says it has formalized a collaboration with the University of Nottingham (Nottingham, U.K.), to establish a new laboratory to accommodate a centre of...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GSK-and-University-of-Nottingham-to-Establish-Laboratory-for-Sustainable-Chemistry_43140.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
